StonvexLoading…
StonvexStonvexStonvexCore line items from PRGO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.25B | $4.37B | $4.66B | $4.45B |
Operating Income | $-1.12B | $112.90M | $151.90M | $78.90M |
Net Income | $-1.43B | $-171.80M | $-12.70M | $-140.60M |
EPS (Diluted) | $-10.29 | $-1.25 | $-0.09 | $-1.04 |
Total Assets | $8.54B | $9.65B | $10.81B | $11.02B |
Total Liabilities | $5.60B | $5.33B | $6.04B | $6.18B |
Cash & Equivalents | $531.60M | $558.80M | $751.30M | $600.70M |
Free Cash Flow OCF − CapEx | $145.10M | $244.60M | $303.80M | $210.90M |
Shares Outstanding | 137.60M | 136.50M | 135.50M | 134.70M |